RxDoctor Payments Data

Tiffany Carlson, DO

Family Medicine · Chico, CANPI 1144581554

Payments from drug & device makers

$1,491in general payments, 2019–2025

Across 80 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$631
  • Dexcom, Inc.$151
  • Amgen$137
  • Lilly USA, LLC$120
  • Pfizer$96
  • Boehringer Ingelheim$67
  • plus $291 from 8 others

What the payments were for

  • Food & beverage$1,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,491 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$266,575
Medicare patients
562
Services billed
4,154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$57,353
RybelsusSemaglutide22$44,714
OzempicSemaglutide23$26,926
TradjentaLinagliptin18$25,431
InvokanaCanagliflozin12$11,420
MounjaroTirzepatide11$9,717
ArexvyRsvpref3 Antigen/As01e/Pf29$9,146
JardianceEmpagliflozin14$8,357
ShingrixVaricella-Zoster Ge/As01b/Pf32$7,142
BelsomraSuvorexant14$6,006
Levothyroxine Sodium479$5,820
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,032
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,390
Atorvastatin Calcium395$2,798
Wixela InhubFluticasone Propion/Salmeterol18$2,718

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$96$57,35353 claims
Boehringer IngelheimTradjenta, Jardiance$67$33,78832 claims
Lilly USA, LLCMounjaro$120$9,71711 claims
MerckBelsomra$61$6,00614 claims
AbbVieSynthroid$631$2,18846 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in Chico

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →